| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |